ESG

Global giant CSL taps Swiss biotech Memo Therapeutics in a landmark deal, signaling a major shift from plasma to lab-grown immunotherapies.

A Japanese innovator is turning discarded textiles into premium building materials, seeking global partners at EuroShop 2026 to scale its circular solution.

A new partnership aims to unlock a vital Swedish rare earth deposit, a project crucial for Europe's green goals but plagued by environmental hurdles.

Median Technologies' eyonis® LCS gains landmark FDA clearance, promising to revolutionize early detection of the deadliest cancer with its AI-powered diagnostics.

Johnson & Johnson unveils promising data for its next-gen AFib tech while reinforcing the safety of its current platform in a competitive market.

Fintech firm SOLOWIN HOLDINGS partners with Alibaba's Taobao Shangou to launch a blockchain-powered system that rewards consumers for low-carbon choices.

The veteran SPAC sponsor closes an upsized IPO for its eighth fund, targeting industrial tech and energy transition with a unique warrant-free structure.

A new Texas facility is turning oilfield wastewater into battery-grade lithium, a historic first step in America's race for critical mineral independence.

Airrosti launches REACH, a new platform combining its proven myofascial release model with digital tools to tackle the $350B MSK problem.

American Battery Technology Co. reports record revenue and a crucial cash flow turning point, accelerating its plans for domestic mineral recycling and mining.

NAPCO Security Technologies heads to key investor conferences, armed with record profits, soaring recurring revenues, and a strong market position.

As Al Barari breaks ground on its final project, we explore the legacy, market impact, and future of Dubai's pioneering nature-led urban oasis.

Amid a parent-company review driven by trade policy, Boviet Solar doubles down on its U.S. manufacturing, highlighting a wider industry trend.

Air Transat lands in Rio de Janeiro, launching an exclusive Montreal route and challenging competitors in Toronto, backed by a key partnership with GOL.

New clinical data reveals a minimally invasive spine implant significantly cuts pain, improves function, and reduces opioid use for SI joint dysfunction.

Tangerine’s socially responsible funds nabbed three prestigious FundGrade A+® Awards, showing investors can align their portfolio with their values without sacrificing performance.

South Korean firm Neurophet wins its third FDA clearance for an AI tool that precisely tracks Alzheimer's therapy side effects, eyeing U.S. expansion.

Copper Intelligence debuts on the US market, securing a high-grade DRC copper asset amid a global shortage and a new US push for critical minerals.

The biotech firm launches clinical-grade solutions at ATW 2026, promising to boost cell therapy quality, consistency, and regulatory alignment.

The CDMO giant's new independently validated system provides clients with auditable carbon data, raising the bar for sustainability in drug manufacturing.